These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22249336)

  • 1. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.
    Jensen K; Johnson LA; Jacobson PA; Kachler S; Kirstein MN; Lamba J; Klotz KN
    Naunyn Schmiedebergs Arch Pharmacol; 2012 May; 385(5):519-25. PubMed ID: 22249336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells.
    Puy JY; Jordheim LP; Cros-Perrial E; Dumontet C; Peyrottes S; Lefebvre-Tournier I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1053():101-110. PubMed ID: 28415014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
    King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
    Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.
    de Wolf C; Jansen R; Yamaguchi H; de Haas M; van de Wetering K; Wijnholds J; Beijnen J; Borst P
    Mol Cancer Ther; 2008 Sep; 7(9):3092-102. PubMed ID: 18765824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
    Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
    Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
    Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
    Bagley RG; Roth S; Kurtzberg LS; Rouleau C; Yao M; Crawford J; Krumbholz R; Lovett D; Schmid S; Teicher BA
    Int J Oncol; 2009 May; 34(5):1329-40. PubMed ID: 19360345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
    Jabbour E; Short NJ; Ravandi F; Huang X; Xiao L; Garcia-Manero G; Plunkett W; Gandhi V; Sasaki K; Pemmaraju N; Daver NG; Borthakur G; Jain N; Konopleva M; Estrov Z; Kadia TM; Wierda WG; DiNardo CD; Brandt M; O'Brien SM; Cortes JE; Kantarjian H
    Cancer; 2017 Nov; 123(22):4430-4439. PubMed ID: 28708931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New substituted 9-alkylpurines as adenosine receptor ligands.
    Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.
    Fredholm BB; Irenius E; Kull B; Schulte G
    Biochem Pharmacol; 2001 Feb; 61(4):443-8. PubMed ID: 11226378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists.
    Volpini R; Costanzi S; Lambertucci C; Vittori S; Cristalli G
    Curr Pharm Des; 2002; 8(26):2285-98. PubMed ID: 12369946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
    Zhang Y; Secrist JA; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML.
    Löfgren C; Albertioni F; Paul C
    Ther Drug Monit; 2005 Oct; 27(5):641-6. PubMed ID: 16175139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
    Harada H; Asano O; Hoshino Y; Yoshikawa S; Matsukura M; Kabasawa Y; Niijima J; Kotake Y; Watanabe N; Kawata T; Inoue T; Horizoe T; Yasuda N; Minami H; Nagata K; Murakami M; Nagaoka J; Kobayashi S; Tanaka I; Abe S
    J Med Chem; 2001 Jan; 44(2):170-9. PubMed ID: 11170626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA.
    Aleskog A; Larsson R; Höglund M; Sundström C; Kristensen J
    Eur J Haematol; 1999 May; 62(5):293-9. PubMed ID: 10359056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
    van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
    J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
    Wilson PK; Szabados E; Mulligan SP; Christopherson RI
    Int J Biochem Cell Biol; 1998 Jul; 30(7):833-42. PubMed ID: 9722988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.